ICON (ICLR) slides as investors stay cautious ahead of delayed results tied to accounting review

ICON plc (ICLR) is down 7.9% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued uncertainty around ICON’s delayed 2025 financials and the ongoing Audit Committee investigation into revenue-recognition practices, which has kept risk appetite fragile into the company’s self-imposed April 30, 2026 reporting deadline. With limited new fundamental clarity until the delayed release, the stock can be prone to sharp moves on positioning, sentiment, and incremental analyst expectation resets.

Details:

ICON previously said its Audit Committee investigation is primarily focused on revenue recognition for fiscal years 2023 through 2025, and it delayed its fourth-quarter and full-year 2025 results while withdrawing prior 2025 financial guidance.

The company has stated it intends to report the delayed results on or prior to April 30, 2026, which can create “event risk” as investors reduce exposure ahead of the update.

Recent analyst actions have reflected the accounting overhang and uncertain near-term visibility, including lowered price targets while maintaining more neutral stance in some cases.

This could also be amplified by broader risk-off trading in outsourced clinical research names when investors focus on cancellations, booking visibility, or higher scrutiny of financial controls.

Sources:

ICON Investor Relations, Yahoo Finance, Investing.com

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive ICLR Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$ICLR Hedge Fund Activity

We have seen 209 institutional investors add shares of $ICLR stock to their portfolio, and 278 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GREENHAVEN ASSOCIATES INC added 1,985,017 shares (+11412.1%) to their portfolio in Q1 2026, for an estimated $219,661,981
CAPITAL WORLD INVESTORS added 1,268,095 shares (+555.2%) to their portfolio in Q4 2025, for an estimated $231,072,270
FMR LLC added 1,164,657 shares (+60.2%) to their portfolio in Q4 2025, for an estimated $212,223,798
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 1,146,520 shares (-32.7%) from their portfolio in Q4 2025, for an estimated $208,918,874
LYRICAL ASSET MANAGEMENT LP added 967,961 shares (+inf%) to their portfolio in Q4 2025, for an estimated $176,381,853
D. E. SHAW & CO., INC. removed 823,782 shares (-55.8%) from their portfolio in Q4 2025, for an estimated $150,109,556
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. added 743,548 shares (+inf%) to their portfolio in Q4 2025, for an estimated $135,489,316

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ICLR Congressional Stock Trading

Members of Congress have traded $ICLR stock 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $ICLR stock by members of Congress over the last 6 months:

REPRESENTATIVE KEVIN HERN sold up to $250,000 on 03/05.
REPRESENTATIVE JULIA LETLOW sold up to $15,000 on 02/12.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$ICLR Price Targets

Multiple analysts have issued price targets for $ICLR recently. We have seen 6 analysts offer price targets for $ICLR in the last 6 months, with a median target of $125.0.

Here are some recent targets:

Sean Dodge from BMO Capital set a target price of $130.0 on 03/26/2026
Patrick Donnelly from Citigroup set a target price of $120.0 on 03/11/2026
Luke Sergott from Barclays set a target price of $120.0 on 03/09/2026
David Windley from Jefferies set a target price of $135.0 on 02/23/2026
Charles Rhyee from TD Cowen set a target price of $120.0 on 02/18/2026
Jailendra Singh from Truist Securities set a target price of $222.0 on 01/08/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.